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Introduction
Microbial keratitis (MK) frequently leads to sight-loss from dense 
corneal scarring, or even loss of the eye, especially when the 
infection is severe and/or appropriate treatment is delayed1. MK 
has been described as a “silent epidemic”, which leads to sub-
stantial morbidity, related to blindness and other consequences 
such as pain and stigma2. It is the leading cause of unilateral 
blindness after cataract in tropical regions and is responsible 
for about 2 million cases of monocular blindness per year3.
In Low and Middle-Income Countries (LMIC), use of 
Traditional Eye Medicine (TEM) for treatment of many eye 
conditions is a common practise4–6. In the few reported studies, 
TEM has been found to lead to complications such as corneal 
scarring and delayed presentation of patients to hospital resulting 
in poor outcomes7,8.
Literature on TEM use for MK is scanty. However, among the 
three papers from Sub-Saharan Africa (SSA), TEM use among 
patients with MK was reported to be associated with a severe 
presentation. These studies did not report clinical outcomes9–11. 
In addition, since most of the TEM involves plant products such 
as fresh leaves, it could have a major role in the pathogenesis of 
fungal keratitis, which has been associated with  injuries involv-
ing vegetative matter12,13. Our experience in Uganda is that TEM 
is widely used to treat a number of eye conditions including 
MK. However, the drivers of this practice are not well understood.
The aim of this study therefore was to determine how TEM 
use impacts presentation and outcome of MK and to explore 
reasons why people use TEM for treatment of MK in Uganda.
Methods
Ethical statement
This study adhered to the Declaration of Helsinki. It was 
approved by the London School of Hygiene & Tropical Medi-
cine Ethics Committee (Ref 10647), Mbarara University Research 
Ethics Committee (Ref 10/04-16) and Uganda National Coun-
cil for Science and Technology (Ref HS-2303). Written informed 
consent in Runyankore, the local language, was obtained 
before enrolment. If the patient was unable to read, the 
information was read to them, and they were asked to indi-
cate their consent by application of their thumbprint. The col-
lected source data is stored in a secure database at Mbarara 
University of Science and Technology. An anonymised digital 
version was also uploaded in a secure server. The data will be 
kept for 7 years according to institutional policy.
Participants
Due to the cultural complexity of TEM usage, we used a mixed 
methods approach. We prospectively enrolled patients with 
MK that consecutively presented to two tertiary eye hospi-
tals in South-Western Uganda from December 2016 to March 
2018. The case deinition of MK was the presence of a corneal 
epithelial defect (of at least 1mm diameter) with an underly-
ing stromal iniltrate, associated with signs of inlammation 
(conjunctival hyperaemia, anterior chamber inlammatory cells, 
+/- hypopyon). We excluded those not willing to participate, those 
not willing to return for follow-up, pregnant women, lactating 
mothers, those aged below 18 years.
Quantitative assessment
We documented basic demographic information and ophthal-
mic history using ophthalmic nurses as part of the routine hos-
pital work up. This included treatment received including prior 
use of TEM. For those who reported use of TEM, a detailed 
structured history was taken on what they had applied, source 
of the medicines, cost, how it was prepared, duration of use and 
any complications experienced. A detailed description of the 
cases evaluation has been previously presented. In summary, 
after measurement of the presenting visual acuity (Logarithm 
of Minimum Angle of Resolution), cases underwent a detailed 
clinical examination on a slit lamp using a structured proto-
col, including eyelid assessment, corneal ulcer features, anterior 
chamber (lare, cells, hypopyon shape and size) and perforation 
status. Corneal scrapes were collected for microscopy, culture 
(blood agar, chocolate agar, potato dextrose agar) and molecular 
diagnosis. HIV, Diabetes counselling and testing were offered, 
as per the Uganda Ministry of Health HIV testing protocol. 
Cases were treated according to the hospital protocol, which 
usually involved a brief admission for the irst few days. The 
study follow-up assessment schedule was days 2, 7, 21 and 
90, to determine outcome. Patients were asked to return to the 
eye hospital for these reviews where their follow up data was 
collected as before. Additional assessments were conducted 
as clinically indicated. The primary outcome measure was 
inal best corrected vision at 3 months. See extended data14 for 
questionnaire used.
Qualitative assessment
All interviews and discussion groups were conducted by AA. 
They were audio recorded and summarised. Additional contex-
tual information provided such as patient emotions, environment 
and any other aspect the interviewer found noteworthy.
Firstly, at presentation, patients who reported to have used TEM 
were asked if they would be willing to discuss their experi-
ences. For such patients, an interviewer would return later that 
evening or the next day when the patient was more relaxed. 
Interviews were conducted in the local language by a social 
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scientist either at the hospital bedside (when quiet) or in the hos-
pital compound depending on the patient’s preference. The focus 
of the interview was to explore reasons why they had used TEM.
Secondly, we conducted informal group discussions (IGDs) with 
a sample of the MK patients involved in the study and relatives 
of people with MK on the practise and reasons why people use 
TEM. This was an opportunistic approach to allow lexible data 
collection. For example, a patient might present escorted by 
many family members and friends (common in this setting), 
such a group would then be invited to discuss issues around 
TEM. Such a naturally composed group was to result in a more 
relaxed discussion than a group of people who did not know each 
other who are brought together solely for the discussion.
Finally, we conducted in-depth interviews with traditional heal-
ers to learn about what they would usually do for people pre-
senting with a problem like MK and why people go to them for 
treatment. Healers were identiied from a traditional healers’ 
registry at the local council headquarters. A random sample of 
15 traditional healers were contacted through their coordinator. 
Those willing to share their knowledge and practise in treating 
eye problems particularly MK were visited and interviewed at 
their home or shrine.
For all the groups, topic guides were developed using available 
literature and experiences of the local ophthalmologists treat-
ing patients with MK (see extended data14). They included 
local understanding of MK, causes, treatment and experiences 
of using TEM. The guides were piloted among a few patients 
and modiied accordingly. The inal version was approved 
by all the authors who included senior social scientists (AA) 
and a professor (JS). In this report, our focus is on reasons why 
people use/do not use TEM. These were reviewed by one of the 
authors. They were then piloted among MK patients and revised 
accordingly. All interviews lasted about 30–45 minutes.
Analysis
Quantitative data were analysed using STATA v14. We com-
pared demographic data, baseline clinical presentation and 
inal vision outcomes at 3-months of patients who reported to 
have used TEM versus those who had not. Appropriate tests of 
signiicance (chi2 for categorical data and Wilcoxon rank sum for 
continuous data) were employed. Multivariable logistic regression 
analysis was used to identify factors associated with TEM use. 
Initially, univariable regression was performed to generate 
crude odds ratios (OR). Variables with a p-value less than 0.1 
were introduced in the multivariable model. A back stepwise 
approach was then used, until only the variables with a p-value 
of less than 0.05 were retained. Adjusted OR were reported for 
the inal model. Summary tables of proportions were constructed 
to describe the source, cost, complications and duration of use 
of TM.
For the qualitative data, all interviews were recorded with an 
audio recorder (Olympus WS-853 Digital Stereo Voice Recorder) 
and transcribed into summaries. These were independently 
reviewed several times by two of the authors (SA and JS). A 
coding framework was developed, and data were then manually 
coded. Emerging themes around reasons why people used/did 
not use TEM are presented. Speciic conversation response clips 
from the respondents that supported the generated themes were 
extracted from the audio recordings and used as illustrative 
statements.
Results
We enrolled 313 people with MK, of whom 188 (60%) reported 
TEM use (“TEM Users”) and 125 said they did not use TEM 
(“TEM Non-Users”). The demographic characteristics of both 
groups are shown in Table 1 (see underlying data14). There were 
some differences between TEM Users and Non-Users. TEM 
Users lived further from the eye unit, were more frequently 
farmers, were less likely to be married and had progressed less in 
formal education.
The clinical characteristics of both groups are shown in 
Table 2. There was evidence that the condition of TEM Users 
was worse than TEM Non-Users at presentation. The TEM Users 
presented later, had larger corneal ulcers (both iniltrate and 
epithelial defect), more frequent hypopyons and poorer vision.
We modelled factors associated with TEM use (Table 3). After 
adjusting for potential confounders, distance from the eye 
hospital and delayed presentation were associated with TEM 
use. Whereas, there was less TEM use among those who were 
married, had a history of trauma and a high education level.
At 3-months, 260 patients completed their follow-up. There was 
no systematic baseline difference between patients who were seen 
at 3-months and those that were not. The inal LogMAR visual 
acuity was worse among TEM Users, median 0.6 (IQR 0-2.5), 
compared to TEM Non-Users, 0.2 (IQR 0-1.5), p=0.010.
Among the 188 patients who reported TEM use, 137 (73%) 
used TEM after they had been to a government health facil-
ity (secondary TEM use). TEM was mostly made from fresh 
leaves [154, (82%)]; the commonest preparation method was to 
freshly squeeze them [145, (77%)]. Most patients obtained TEM 
either from their home garden (40%) or from a neighbour (54%), 
only 5 patients (3%) obtained TEM from a traditional healer. 
TEM was generally free, 169 (90%) reported not to have spent 
any money to obtain it.
The qualitative study involved a total of 38 participants: 11 
traditional healers, 21 MK patients who had used TEM and 6 
MK patients who had not used TEM. The baseline character-
istics of these individuals are presented in Table 4. Overall, it 
was a mix of male and female, young and old, not educated 
and highly educated. In addition, three informal group discus-
sions (IGDs) were conducted, each with around 15 partici-
pants (these were naturally composed groups of patients who 
had used or not used TEM, relatives and friends).
The major factors coming out as the reasons for using TEM 
included lack of consumer conidence in conventional medi-
cine, health system breakdown, poverty, fear, cultural belief in 
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Table 2. Baseline clinical characteristics of participants (n=313), comparing traditional eye medicine (TEM) users to 
non-users.
Variable
TEM Users (188) TEM Non-Users (125)
Median (IQR) (Total range) Median (IQR) (Total range) P value
Presentation time in days 18 (12–35) (1–274) 14 (5–32) (0–370) 0.005
Infiltrate size in mm* 5.6 (3.8–8.1) (0.5–11) 4.3 (2.4–6.8) (0.6–12) 0.0005
Epithelial defect size in mm* 4.2 (2.5–11) (0–14) 3.6 (2.2–5.1) (0–11) 0.0105
Presenting Vision (Log MAR) 1.5 (0.3–2.5) (0–4) 0.6 (0.2–2.5) (0–4) 0.005
Count (%) count (%) P value
Visual Acuity > 6/18 50 (27) 52 (42) 0.011
6/18 – 6/60 24 (13) 18 (14)
< 6/60 113 (60) 55 (44)
Eye discharge Yes 107 (57) 60 (48) 0.122
History of Trauma Yes 42 (22) 49 (39) 0.001
Presence of lid swelling Yes 85 (46) 45 (36) 0.097
Slough ř None 31 (17) 30 (24) 0.246
Flat 77 (41) 47 (38)
Raised 78 (42) 46 (37)
Infiltrate colour White 77 (44) 71 (63) 0.005
Cream 76 (43) 30 (27)
Other 23 (13) 11 (10)
Table 1. Baseline demographics characteristics of participants (n=313), comparing traditional eye medicine (TEM) 
users to non-users.
Variable
TEM Users (188) TEM Non-Users (125)
Median (IQR) (Total range) Median (IQR) (Total range) P value
Age 48 (34–60) (18–87) 45 (35–60) (18–96) 0.651
Distance to eye hospital (km) 87 (59–132) (1.5–378) 67 (42–121) (0.2–316) 0.003
Distance to nearest Health Centre in (km) 3 (1–5) (0–45) 2 (1–4) (0–35) 0.528
Count (%) count (%) P value
Gender Male 101 (54) 73 (58) 0.415
Occupation Farmer 140 (75) 80 (64) 0.047
Non-farmer 48 (25) 45 (34)
Education None 59 (31) 25 (20) 0.016
Primary Level 98 (52) 64 (51)
Secondary Level 23 (12) 22 (18)
Tertiary Level 8 (5) 14 (11)
Marital status Unmarried* 66 (35) 29 (23) 0.025
Married 122 (65) 96 (77)
Household SES ř Poor 51 (28) 34 (29) 0.520
Middle 116 (64) 72 (60)
Upper 13 (7) 13 (11)
SES: Socioeconomic status.
*Unmarried included-single, divorced, widowed. ř This was relative self-reported economic status compared to the neighbours.
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Table 3. Univariable and multivariable logistic regression for factors associated with traditional eye medicine use (n=313).
Variable Univariable Analysis Multivariable Analysis
Crude OR (95% CI) p-value Adjusted OR (95% CI) p-value
Age in years 1.002 (0.988-1.016) 0.699
Distance to Eye hospital (for every km) 1.005 (1.001-1.0090 0.009 1.004 (1.001-1.008) 0.035
Distance to the nearest Health Centre (for every km) 1.028 (0.971-1.089) 0.332
Sex (Being male) 0.82 (0.52-1.30) 0.415
Occupation (Being a farmer) 1.64 (1.01-2.68) 0.048
Married 0.55 (0.33-0.93) 0.026 0.54 (0.31-0.95) 0.035
Education level
None 1 0.016 1 0.059
Primary 0.64 (0.36-1.14) 0.71 (0.38-1.30)
Secondary 0.44 (0.20-0.93) 0.44 (0.20-1.00)
Tertiary 0.24 (0.09-0.65) 0.28 (0.09-0.83)
Household economic status
Low 1 0.526
Middle 1.07 (0.63-1.81)
Upper 0.66 (0.27-1.61)
Presentation time
0–3 days 1 <0.001 1 0.002
4–7 days 2.17 (0.72-6.53) 1.50 (0.46-4.83)
8–14 days 6.03 (2.10-17.3) 4.76 (1.55-14.6)
15–30 days 5.77 (2.03-16.4) 4.37 (1.44-13.2)
>30 days 4.89 (1.75-13.6) 3.74 (1.27-11.1)
History of trauma 0.44 (0.26-0.72) 0.001 0.43 (0.25-0.74) 0.003
Variable
TEM Users (188) TEM Non-Users (125)
Median (IQR) (Total range) Median (IQR) (Total range) P value
Hypopyon Yes 66 (35) 28 (22) 0.014
Perforated at admission Yes 29 (15) 16 (13) 0.517
Microbiology Unknown 38 (23) 27 (25) 0.089
Bacteria 10 (6) 10 (10)
Fungus 108 (67) 60 (55)
Mixed 6 (4) 11 (10)
Log MAR: Logarithm of the minimum angle of resolution.
*These were calculated as the geometrical means using the MUTT protocol15. The upper limits exceeded normal corneal diameter for some 
lesions, which extended up to the sclera. ř Raised slough was when the corneal infiltrate profile was raised, flat slough was when the profile 
was flat while no slough is when there was no debris noted. The difference in presenting vision and infiltrate sizes remained significant even 
after adjusting for delayed presentation.
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Table 4. Baseline characteristics of people who participated in the in-depth interviews, including 
traditional healers and patients with microbial keratitis (both traditional eye medicine (TEM) users 
and non-users).
Participant Age Sex Marital status Occupation Household size Education Religion
Traditional Healers (n=11)
1 70 Male Divorced Farmer 1 None Christian
2 56 Female Married Farmer 4 None Christian
3 52 Female Widowed Farmer 3 None Christian
4 76 Female Married Farmer 8 Primary Christian
5 78 Female Married Farmer 5 - -
6 53 Female Widowed Farmer 2 - Christian
7 72 Female Widowed TBA 4 Primary Christian
8 82 Male Divorced Farmer 8 None Christian
9 59 Male Married Carpenter 18 Secondary Christian
10 69 Female Married TBA 6 Primary Christian
11 60 Female Widowed TBA 5 Primary Christian
TEM Users (n=21)
1 42 Male Married Farmer 7 Primary Christian
2 46 Male Married Charcoal maker 8 Primary Christian
3 26 Male Married Mechanic 4 Primary Christian
4 53 Female Married Farmer 5 Primary Christian
5 38 Female Married Farmer 3 Primary Christian
6 26 Male Single Graduate 5 Tertiary Christian
7 18 Female Single Farmer 6 Secondary Christian
8 39 Male Married Farmer 5 None Muslim
9 85 Female Widowed Farmer 18 None Christian
10 60 Female Married Business 5 None Christian
11 72 Female Married Farmer 8 None Christian
12 29 Male Married Teacher 3 Tertiary Christian
13 60 Male Married Farmer 6 Primary Muslim
14 39 Female Married Farmer 5 Primary Christian
15 54 Male Married Guard 4 Primary Christian
16 58 Female Married Farmer 4 Primary Christian
17 30 Female Divorced Farmer 4 Primary Christian
18 81 Male Married Farmer 9 None Christian
19 81 Male Married Farmer 5 Primary Christian
20 69 Male Married Farmer 17 Primary Christian
21 20 Male Single Shop keeper 20 Primary Muslim
TEM Non-Users (n=6)
1 56 Male Married Teacher 6 Tertiary Christian
2 25 Male Married Bike rider 6 Primary Christian
3 39 Male Married Accountant 1 Tertiary Christian
4 30 Female Single Hairdresser 1 Primary Christian
5 20 Male Single Farmer 10 Secondary Christian
6 19 Female Single Student 4 Tertiary Muslim
TBA: Traditional Birth Attendant;
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TEM, Role of Traditional Healers, personal circumstances and 
Ignorance.
Lack of confidence in conventional medicine
While some participants reported visiting health centres for 
treatment, many talked of resorting to TEM with the persist-
ence in pain after use of conventional medicine. A 26-year male 
mechanic said “At first, I got some relief when I put the eye 
drop, but later, it pained me severely and I was advised to use 
herbs. Having seen no great improvement, I started using herbs.” 
A participant in an IGD told us “We are using western medi-
cine to no avail. You can use western medicine for a week or a 
month but don’t get healed.” A 75-year male traditional healer 
reported that “many people with eye problems come to me 
because some even fail to get cured from Mbarara hospital and 
are referred to me. I then put my traditional eye medicine like 
twice and they gain or enjoy life again.” These statements sup-
ported the observation above that the majority (73%) of the TEM 
users had applied it after they had visited a health facility.
Lack of service in health facilities
Inadequate care including lack of medicines, rude health work-
ers, unskilled health workers and poorly equipped health 
facilities, especially government owned ones, were reported as 
major drivers to use of TEM by a majority of patients. “There 
are no experts or doctors experienced in treating eye diseases 
in Health Centres within our vicinities. When you find a 
doctor at a Health Centre, they say that they don’t know such an 
eye disease you are suffering from” (a 28-year unemployed man). 
The majority of primary health facilities do not have trained 
primary eye care workers. Eye patients are reviewed by 
general health workers who may have limited experience with 
managing ophthalmic condition. Eye care workers are nurses 
who have received an ophthalmic certiicate course in examina-
tion and management of common eye conditions. In addition, 
as an 81-year-old farmer put it “Health facilities within our 
areas don’t have eye medicine, examination machines and they 
are also unwelcoming to a person who has gone there. One just 
looks at the eye, prescribes the medicine and start treating the 
illness. Or, you hear medicine has been brought but when you 
go there the next day, you are told there is no medicine.” 
Poverty as a barrier to access care
With subsistence farmers constituting the major part of the pop-
ulation, poverty was reported as a key barrier to accessing eye 
care, encouraging people to opt for TEM. This was expressed 
as being unable to afford transport to eye hospitals and treat-
ment. In an IGD1, one respondent told us “Those of us who are 
able to afford treatment are very few you can count them; many 
people who have the same problem have turned blind because 
they cannot afford treatment.” Another person added “It’s a result 
of poverty! Many people in the village have no money. Even 
sometimes you don’t have money in the pocket, so you pick the 
herb and apply it to the sick eye. You get to come here at the 
facility when you can’t count the types of herbs you have tried 
just because of poverty.” Compared to going to hospital and the 
costs involved, TEM was a far cheaper option: the majority of 
the patients had obtained it from within their homesteads and had 
not spent any money on it.
Fear of the eye hospital
Most people lived far from the eye hospital and fear of travel-
ling long distances, which was reported as a constraint. “One 
can be having money but chooses not come to the hospital 
fearing how he will reach. Not all people are poor, but one just 
wonders where he is to pass and continue to Mbarara eye 
hospital. There are reluctant for example one says he won’t be 
able to reach the place he has never gone to” (an 81-year old male 
farmer from a distant village). We found that most of the 
patients travelled l distances (about 90 km) to reach the only 
referral eye hospitals in Mbarara town. Another form of fear 
was of what treatment would be offered; some people thought 
that this would make them go blind. For example, a participant 
in IGD2 told us “What stops them from going to the hospital is 
that one is told they are going to operate your eye and after that 
it means that it is damaged completely you will never see again. 
That is the reason many people fear coming to the hospital, 
they say when you are operated the eye ends up getting dam-
aged. They say when you reach in the hospital and get operated, 
it doesn’t get well” 
Cultural understanding of MK and its treatment
Use of TEM in general is viewed as an acceptable practice 
and as part of culture in the community. It was revealed by 
several participants that MK is culturally understood as a disease 
to be treated locally. Almost all participants talked of receiving 
advice to use TEM from fellow community members who 
attest that it cured them. An 81-year old female farmer told us 
“People in communities don’t know that MK as an eye disease 
is treated in hospitals or that there are hospitals that can treat 
it. People say it is cured by traditional eye medicine.” Another 
42-year old farmer said “The old people we live with know 
those medicines and they testify that they cured them. Therefore, 
they encourage one who is suffering from an eye disease to keep 
using them saying he too will get well.” Most of the people came 
from rural settings where there is a strong sense of community.
Belief in TEM
From the experience of previous TEM users and personal 
experience of use, it was not surprising that almost all par-
ticipants who had used TEM believed it was effective. They 
attributed their failure to heal to their body makeup. “The old 
people believe and know that traditional eye medicine cures eye 
diseases. There are people, they identified for me who used the 
same medicine and got well. Even themselves, they told me that 
they used it and got cured” (a 42-year male farmer). “The 
person who gave me traditional eye medicine told me she too 
suffered from the same disease and got healed by the same 
herbs” (a 60-year old butter maker). On being asked why it had 
not worked for them, a 53-year old female farmer responded 
“those who don’t heal I think the condition of the eye might 
have needed medical attention from doctors as genetically 
people are different. There is one who heals by traditional 
eye medicine and another who doesn’t and is only treated by 
modern medicine from hospitals.” 
Role of traditional healers
With the belief and acceptance that use of TEM is within 
their culture, many had conidence in traditional healers. The 
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traditional healers themselves also had a strong conidence in 
their medicine and reported remarkable cure rates. One 56-year 
old traditional healer said: “They go to the hospitals and 
come back to me when they have failed to heal with modern 
medicine. I give them traditional eye medicine and they get healed, 
none that I have treated or given my medicine has failed to get 
well” Another 75-year old male healer reported “There are 
many people I have treated; none I gave my medicine has 
ever complained that it failed to heal her or him. Whoever I 
meet just praises God and prays for me to be blessed. I treat 
people with faith in God.” 
Personal circumstances
Desperation due to the pain of the condition and the view of 
TEM as a form of irst aid was mentioned as a prompt to use 
traditional medicine. This was mostly reported among patients 
who used TEM before presenting to health facilities. Participants 
explained that with the pain, one can use anything recommended 
to him or her to the extent of accepting TEM containing needle 
prick blood from another person without being afraid of con-
tracting HIV. A 42-year male farmer told us “This disease is so 
painful. No one should suffer from it because, with pain you 
can use anything given to you. You are not mindful of HIV, you 
only want the pain gone”. A 85-year female farmer wondered, 
“Can anyone who has been found in pain and recommended an 
herb fail to use it? Pain can make you do anything”.
Lack of awareness to the dangers of TEM
Interestingly, most participants did not think using TEM could 
be dangerous. “Traditional eye medicine doesn’t damage the 
eye, it just rinses or cleanses it” (a 46-year old male charcoal 
burner). “There are no risks of using traditional eye medicine 
because when one fails to get healed, she or he goes somewhere 
else or to hospitals” (an 85-year female farmer). In addition, 
some thought it was better than conventional medicine and did 
not have any side effects like most conventional medicines. 
A 59-year old traditional healer said, “Our herbal medicine 
is fresh not preserved.” 
Discussion
This study investigated the extent of TEM use by people with 
microbial keratitis, and how this impacts their clinical presenta-
tion and outcome. We went on to explore more deeply the spe-
ciic practices and the reasons and beliefs behind using TEM. 
The use of TEM in Southern Uganda in the treatment of MK is 
common (60%), and more frequent than that previously reported 
from Malawi (34%) and Tanzania (25%)9,10. Importantly, we 
found that people who used TEM presented later with a more 
severe clinical picture and they ended up with worse inal 
visual acuity outcomes at 3-months, compared to those who 
had not used TEM.
Our indings are similar to previous reports from Malawi, which 
found that patients who had used TEM presented later than 
those who had not used TEM9,16. The previous studies, how-
ever, did not examine inal outcomes, after the infection had 
been treated. MK is a disease where prompt treatment is critical 
if one is to improve the likelihood of a good outcome. We know 
from prior literature that once an infection is advanced, treat-
ment does relatively little to change its course17. The clear 
conclusion from earlier studies from South Asia and East 
Africa is that effective treatment of MK should be started as 
early as possible to save the eye and achieve the best possible 
outcomes18,19.
In this study we combined both quantitative modelling 
approaches and complementary qualitative approaches to inves-
tigate not only “what” but also “why” people use TEM. In the 
explanatory multivariable model, increasing distance to the eye 
hospital, lower education level, an onset not linked to trauma and 
not being married were associated with TEM use. These were 
explored further in the informal group discussions (IGDs). 
These discussions the major reported reasons for using TEM 
were around consumer conidence in the health system, access, 
poverty and cultural inluence.
Importantly, we found that most people who used TEM did so 
after irst visiting a government health facility. This is consistent 
with the IGDs, in which people felt that conventional medicine 
was not helping, leading them to resort to alternative approaches. 
This conclusion could be a result of inappropriate treatment. 
However, even with appropriate treatment, the clinical response 
can be slow, especially for fungal keratitis. Patients need to 
be properly counselled to manage expectations. Another impor-
tant aspect is good pain management on top of the anti-microbial 
treatment. Patients reported that desperation due to pain made 
them more likely to try many options to ind relief. This initial 
early contact point with the formal health system represents 
an opportunity to improve the diagnosis and treatment of 
people with MK, through providing enhanced training, diagnostic 
tools and medication in the primary care setting.
Lack of appropriate ophthalmic medicines is a major challenge. 
For example, the best current evidence indicates that topical 
natamycin is the treatment of choice for ilamentous fungal 
keratitis20. However, this is currently not readily available in 
the main ophthalmic units Uganda or elsewhere in SSA. It is 
certainly not available in more isolated locations. Therefore, 
patients with a fungal MK will not access effective treatment 
until they arrive in a major eye unit. Natamycin was added 
to the WHO Essential Medicines List in 2018, which will 
hopefully result in greater availability soon.
Limited access to eye care was a major driver of TEM use. This 
was evident in the regression modelling, with increasing TEM 
use with increasing distance to the eye hospitals. The majority of 
TEM users came from districts relatively far away where no eye 
care facilities were situated. This was a strong and frequently 
articulated theme in the interviews and discussions. Multiple 
people commented on the lack of eye health services in the 
nearby health facilities, the long distances to the eye hospi-
tal and poverty is a major barrier to access (because of the high 
transport and other direct costs). Several people also highlighted 
that government health centres near to them have no eye spe-
cialists or treatment and do not treat eye conditions. Pharmacies 
simply sell available eye drop medication, with no examination; 
frequently these are steroid and antibiotic combinations which may 
result in more harm than good in fungal keratitis. Unfortunately, 
Uganda still grapples with a severe shortage of human resources 
and infrastructure for eye health21.
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Although the regression model did not demonstrate a relation-
ship between economic status and TEM Use, during the IGDs 
poverty was reported to be a major driver for using TEM. In the 
model, there were only a handful of people in the upper eco-
nomic status which may have obscured this relationship. The 
majority of the patients were subsistence farmers and therefore 
not able to readily afford the cost of medicines and transpor-
tation. In contrast, TEM could be accessed closer to home at 
almost no cost. Most of the patients used got the TEM from their 
nearby gardens or from the neighbour and applied it freshly 
squeezed into the eye. People who are married may have 
access to greater household inancial resources, possibly 
explaining why being married was associated with less TEM use.
We found that TEM use was linked to strong cultural beliefs 
and this seemed related to the level of education. In the model, 
people with no or little education were more likely to use 
TEM. It was worrying that people did not perceive TEM use as 
potentially dangerous. This was also reinforced by messages 
from traditional healers and older members of the commu-
nity who carry a high level of respect. Public health orientated 
messaging and health education need to particularly focus on and 
work with these groups. There is some evidence from Malawi 
and Nigeria, where ophthalmologists worked with traditional 
healers to lower the use of TEM, that changes are possible7,16. 
Although, in our context, only 3% of TEM users consulted a tra-
ditional healer, their place in society cannot be underestimated 
and it would be in our best interest to bring them on board.
Strengths/limitations
The use of a mixed methods approach provided a more inform-
ative data on reasons for using TEM for MK in Uganda. To the 
best of our knowledge, this was the irst study in SSA that 
looked at 3-month outcomes of people who had used TEM 
for treatment of MK. Although a sensitive topic, it was noted 
that participants and traditional healers were willing to talk 
about their TEM experiences. We did not have any evidence that 
people withheld information. The large numbers were enough 
to have a well powered study to explore factors associated 
with TEM use. Inclusion of children would have provided a 
more overall understanding of this topic, however, this was 
not practical in out setting.
Conclusion
TEM use is an important factor in the presentation and out-
come of MK in Uganda, leading to delayed presentation to hos-
pital, a poor presentation and a worse outcome. Cultural beliefs, 
access to the health system (due to poverty and long distances) 
and inherent challenges in the primary health centres (lack of 
knowledge, medicines, equipment and supplies) are major 
drivers of TEM use. Sensitisation of the people and capacity 
building in the primary health centres will be a step in the right 
direction to mitigate these effects.
Data availability
Underlying data
Havard dataverse: Traditional Eye Medicine use in Microbial 
Keratitis in Uganda. https://doi.org/10.7910/DVN/5GOPKZ14.
This project contains the following underlying data:
•    tem_data_descriptive_5May2019.tab (quantitative underly-
ing data)
•    tem_coding_framework_May2019.tab (codes of qualitative 
data responses)
Extended data
Havard dataverse: “Topic guides for exploring Traditional 
Eye Medicine Use for treatment of Microbial Keratitis in 
Uganda.docx”, Traditional Eye Medicine use in Microbial 
Keratitis in Uganda, https://doi.org/10.7910/DVN/5GOPKZ14.
This project contains the following underlying data
•    Topic guides for exploring Traditional Eye Medicine 
Use for treatment of Microbial Keratitis in Uganda.docx 
(Topic guides that were used to probe respondents to 
talk about their understanding, opinions and experiences 
of using Traditional Eye Medicine)
•    Quantitative questionnaire on use of Traditional Eye 
Medicine.docx (A of a quantitative questionnaire that was 
used to collect information from all the patients with MK 
on their history of use of Traditional Eye Medicine)
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
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